Stress, generally defined as any stimulus that disrupts the body's internal balance (i.e., physiological homeostasis), has long been suggested to be an important correlate of uncontrolled alcohol consumption or relapse to drinking following a period of abstinence. Large epidemiological studies have reported that a variety of stressors are associated with increased alcohol consumption and binge drinking. These include hazardous and demanding work environments, legal stress, family stress (e.g., unhappy marriage and divorce), and low income ([@b106-arcr-34-4-468]; [@b108-arcr-34-4-468]; [@b111-arcr-34-4-468]; [@b135-arcr-34-4-468]). Likewise, the Health and Retirement Study found an association between stress from retirement and divorce and increased alcohol intake ([@b99-arcr-34-4-468]). Studies also have shown that people experiencing more severe or highly threatening social stress following alcoholism treatment have higher rates of relapse compared with people not experiencing such stress ([@b18-arcr-34-4-468]; [@b93-arcr-34-4-468]). On the other hand, prospective and human laboratory studies exploring the relationship between stress, alcohol craving, and relapse have found mixed results, with more recent research suggesting that several factors moderate the effects of stress on alcohol consumption (e.g., [@b16-arcr-34-4-468]; [@b17-arcr-34-4-468]; [@b39-arcr-34-4-468]; [@b56-arcr-34-4-468]; [@b120-arcr-34-4-468]; [@b120-arcr-34-4-468]; [@b126-arcr-34-4-468]).

It remains uncertain how stress, per se, might influence vulnerability to alcohol use disorders (AUDs). However, production of the stress hormone cortisol, which is triggered by stress-induced activation of a hormonal system known as the hypothalamic--pituitary--adrenal (HPA) axis, is thought to be involved. The HPA axis is one of the main stress response pathways and has been studied extensively in relation to alcohol use ([@b140-arcr-34-4-468]). Over 20 years of research has demonstrated that altered HPA axis regulation is associated with problematic alcohol use and dependence and that the nature of this dysregulation varies with respect to the stages of progression toward alcohol dependence. The finding that HPA axis dysregulation and alcohol misuse tend to co-vary has implied a "guilt-by-association" relationship---that is, that abnormal variations in stress-related cortisol production are a risk factor for developing alcoholism in the first place ([@b142-arcr-34-4-468]). A recent review of studies on youth and adolescents similarly suggests that HPA axis dysfunction and exposure to stress are critical components that interact to convey risk for developing AUDs ([@b114-arcr-34-4-468]).

As with mood and affective disorders, many researchers consider alterations in HPA axis function crucial for understanding the underlying brain mechanisms of substance use disorders. In contrast to mood and affective disorders, however, alcohol dependence has a biphasic effect on HPA axis dynamics as a person traverses through the various phases of heavy hazardous drinking, including dependent drinking, withdrawal, abstinence, and relapse. Generally speaking, these developmental stages seem to be mirrored by a shift between hyper- and hyporesponsiveness of the HPA axis to stressful events ([@b107-arcr-34-4-468]). For example, hyperresponsiveness has been identified in people with a family history of alcoholism ([@b130-arcr-34-4-468]; [@b160-arcr-34-4-468],[@b161-arcr-34-4-468]), a population that is at increased risk for alcohol dependence ([@b153-arcr-34-4-468]). This observation raises the question whether heightened stress responsivity is clinically meaningful to the development of alcoholism. This view is supported by studies showing that cortisol responsivity correlates with the activity of a brain system, the mesolimbic dopaminergic pathway, which is a central neural reward pathway ([@b95-arcr-34-4-468]; [@b147-arcr-34-4-468]). With transition to alcohol dependence, compensatory allostatic mechanisms result in injury to HPA axis function and elevation of stress peptide levels (e.g., corticotropin-releasing factor \[CRF\]) in brain regions outside the hypothalamus. The term allostasis refers to the process through which various biological processes attempt to restore homeostasis when an organism is threatened by various types of stress in the internal or external environment. Allostatic responses can involve alterations in HPA axis function, the nervous system, various signaling molecules in the body, or other systems. Allostatic alterations in HPA axis function have been posited to, among other things, injure brain reward pathways, contribute to depressed mood (i.e., dysphoria) and craving, and further contribute to the maintenance of problem drinking behavior.

This article provides an overview of the clinical evidence for HPA axis and glucocorticoid dysfunction across the developmental phases of alcoholism and explores whether this dysfunction is causally related to, or a consequence of, alcohol dependence. The article describes behavioral and physiological pathogenesis resulting from dysregulation of basal and reactive HPA axis activity. This discussion primarily focuses on human studies and studies that specifically address the glucocorticoid activation component of the stress response. The article also discusses whether these findings have potential predictive value and whether altered glucocorticoid function, regardless of etiology, may serve as a useful clinical marker for the progression of alcohol dependence and treatment prognosis. The review will not address the important role that extrahypothalamic CRF pathways play in mediating the relationship of stress and reward dysfunction (for a review of this issue, see [@b75-arcr-34-4-468]).

Physiology of the HPA Axis
==========================

The body responds to stress with self-regulating, allostatic processes aimed at returning critical systems to a set point within a narrow range of operation that ensures survival. These self-regulating processes include multiple behavioral and physiological components. Perhaps the best-studied component of the stress response in humans and mammals is activation of the HPA axis (see [figure 1](#f1-arcr-34-4-468){ref-type="fig"}). Neurons in the paraventricular nucleus (PVN) of the hypothalamus release two neurohormones---CRF and arginine vasopressin (AVP)---into the blood vessels connecting the hypothalamus and the pituitary gland (i.e., hypophysial portal blood). Both hormones stimulate the anterior pituitary gland to produce and secrete adrenocorticotropic hormone (ACTH) into the general circulation. The ACTH, in turn, induces glucocorticoid synthesis and release from the adrenal glands, which are located atop the kidneys. The main glucocorticoid in humans is cortisol; the main glucocorticoid in rodents, which frequently are used as model systems to investigate the relationship between stress and alcohol use, is corticosterone. Hypothalamic activation of the HPA axis is modulated by a variety of brain signaling (i.e., neurotransmitter) systems. Some of these systems have inhibitory effects (e.g., γ-aminobutyric acid \[GABA\] and opioids), whereas others have excitatory effects (e.g., norepinephrine and serotonin) on the PVN. Thus, the central nervous system (CNS) and the hormone (i.e., endocrine) system are tightly interconnected to coordinate glucocorticoid activity.

To protect against prolonged activity, the HPA system is carefully modulated through negative-feedback loops designed to maintain predetermined hormone levels (i.e., set points) and homeostasis. To this end, secretion of CRF, AVP, and ACTH in part are controlled by sensitive negative feedback exerted by cortisol at the level of the anterior pituitary gland, PVN, and hippocampus. There are two types of receptors for cortisol---mineralocorticoid (type-I) and glucocorticoid (type-II) receptors---both of which participate in the negative-feedback mechanisms. Cortisol binds more strongly (i.e., has higher binding affinity) for the mineralocorticoid receptors (MRs)[^1^](#fn1-arcr-34-4-468){ref-type="fn"} than the glucocorticoid receptors (GRs). Because of this difference in binding affinity, the MRs help maintain the relatively low cortisol levels circulating in the blood during the normal daily (i.e., circadian) rhythm. Only when the cortisol concentration is high (e.g., during a stressful situation) does it bind to the GRs with lower affinity; the resulting activation of the GRs terminates the stress response. This delicate negative feedback control mechanism maintains the secretion of ACTH and cortisol within a relatively narrow bandwidth. This is an extremely important homeostatic mechanism because too much or too little exposure to cortisol can have adverse consequences to health and well being.

Growing evidence suggests that a protein, FK506 binding protein 5 (FKBP5), regulates GR sensitivity. Binding of this protein to the GR reduces the receptor's affinity for cortisol and its movement (i.e., translocation) to the nucleus. A genetic variation in FKBP5 is associated with enhanced expression of the protein following GR activation. This leads to more GR resistance, diminished negative feedback, and prolonged stress hormone activation following a stressor ([@b14-arcr-34-4-468]; [@b155-arcr-34-4-468]).

Physiological Actions of Glucocorticoids
----------------------------------------

Glucocorticoids are a class of steroid hormones that are essential for the organism to survive. Cortisol, the main glucocorticoid in humans, has been placed in this class because of its effects on the metabolism of the sugar glucose, where its primary function is to increase blood glucose levels by inducing production of additional glucose molecules (i.e., gluconeogenesis). Cortisol also modifies fat and protein metabolism to support the nutrient requirements of the CNS during stress. However, cortisol also has many other wide-ranging effects when it binds to GRs. For example, it influences cardiovascular function, immunologic status (i.e., inflammatory reactions), arousal, and learning and memory; all of these systems therefore are affected when the HPA axis is activated in response to stress.[^2^](#fn2-arcr-34-4-468){ref-type="fn"} Thus, cortisol helps maintain or can increase blood pressure by increasing the sensitivity of the blood vessels to signaling molecules, catecholamines. In the absence of cortisol, widening of the blood vessels (i.e., vasodilation) and hypotension occurs. The anti-inflammatory effects of cortisol are brought about by reducing proinflammatory cytokine and histamine secretion and stabilizing the membranes of cell components, lysosomes.

One of the most important actions of cortisol in the context of alcohol use and the stress response is its role in modifying learning and memory. Both stress and exposure to cortisol can transiently block memory retrieval ([@b133-arcr-34-4-468]), with retrieval of emotional memory more strongly affected than that of neutral memory. Of interest, both cortisol and stress also enhance memory consolidation; this process generally favors consolidation of emotionally arousing information, facilitating habit-based learning.

Consistent with the multiple-systems theory to memory organization in the mammalian CNS, studies have identified unique roles for various brain regions in learning and memory. For example, "cognitive" learning and memory is associated with activation of brain circuits in the hippocampus, whereas "habit" learning and memory is associated with activation of the dorsal striatum and the basolateral amygdala (BLA). In addition, nerve fibers projecting from the BLA modulate memory processes occurring in other brain structures. The implications of the fact that cortisol selectively affects emotionally charged memory and habit learning are discussed below.

Determinants of HPA Axis Activity and Cortisol Exposure
-------------------------------------------------------

Correct regulation of cortisol levels is necessary for survival, and too little or too much cortisol exposure can result in serious harm. Therefore, both basal and stress-induced cortisol levels are maintained carefully. A healthy stress response is characterized by a quick rise in cortisol levels, followed by a rapid decline with the termination of the stressful event. When the organism is burdened by cumulative stress, however, the cortisol burden increases. This results in wear and tear on the organism from excessive exposure to the catabolic properties of glucocorticoids, stress peptides, and proinflammatory cytokines. This burden taxes the organism and can influence the development of neuropsychiatric and metabolic disorders. It therefore is essential to understand the systems that regulate cortisol production.

Three main determinants of HPA axis activity control the amount of cortisol a person is exposed to during adulthood: genetic background, early-life environment, and current life stress. In addition, studies found that post-traumatic stress disorder (PTSD) can contribute to HPA axis disturbances.

### Genetic Factors

Differences among individuals in cortisol responses to stress result from a complex interplay between genetic and environmental factors. The genetic contribution to the variability in HPA axis reactivity is believed to arise from DNA variations (i.e., polymorphisms) in the genes encoding neurotransmitters involved in HPA axis regulation. Overall, heritable influences account for approximately 62 percent of the etiological variance in basal glucocorticoid levels ([@b8-arcr-34-4-468]). Recent candidate gene association studies using laboratory-based stress procedures also have implicated multiple gene variants in explaining some of the variance in cortisol responses to stress, including polymorphisms in the following genes: *Nr3c1*, which encodes a glucocorticoid receptor protein ([@b157-arcr-34-4-468]);*Nr3c2*, which encodes a mineralocorticoid receptor protein ([@b27-arcr-34-4-468]);*FKBP5* ([@b60-arcr-34-4-468]);*CRFR1*, which encodes the CRF receptor 1 protein ([@b21-arcr-34-4-468]);*CRF-BP*, which encodes CRF binding protein ([@b148-arcr-34-4-468]);*GABRA6*, which encodes the GABA receptor subunit alpha-6 protein ([@b129-arcr-34-4-468]);*OPRM1*, which encodes the mu opioid receptor protein ([@b20-arcr-34-4-468]); and*SLC6A4*, which encodes a serotonin transporter protein ([@b149-arcr-34-4-468]).

It is certain that additional genes and polymorphisms will be identified in the future.

### Early-Life Environment

Pre- and postnatal processes contribute to the lifelong responsiveness of the HPA axis to stressors. In animal models, prenatal ethanol exposure is associated with impaired HPA axis responsivity in adulthood ([@b55-arcr-34-4-468]; [@b151-arcr-34-4-468]), and emerging evidence suggests that these effects also occur in human infants and toddlers ([@b45-arcr-34-4-468]; Ouellet-Morin et al. 2010). Maternal stress during gestation also modifies HPA axis responsivity of infant and adult offspring (see [@b19-arcr-34-4-468]; [@b49-arcr-34-4-468] for reviews). More recently, studies have focused on the consequences of early-childhood events on the stress response. Childhood trauma is a significant problem in the United States and is associated with mental and physical health problems in adulthood as well as with alterations in HPA axis function ([@b51-arcr-34-4-468], [@b54-arcr-34-4-468]; [@b29-arcr-34-4-468]; [@b82-arcr-34-4-468]). For example, it has been hypothesized that exposure to sexual and physical abuse in childhood during critical periods of brain development (i.e., during periods of neural plasticity) may permanently alter stress responsivity ([@b40-arcr-34-4-468]; [@b52-arcr-34-4-468]; [@b52-arcr-34-4-468]). Animal models that have studied this phenomenon have shown that certain forms of neonatal stress results in a modification (i.e., epigenetic methylation) of the glucocorticoid gene that has long-lasting effects on glucocorticoid responsivity ([@b150-arcr-34-4-468]). This alteration in stress responsivity may explain the observation that childhood adversity is a risk factor for the development of alcohol and other drug abuse ([@b33-arcr-34-4-468]) as well as anxiety and depressive disorders in adulthood ([@b69-arcr-34-4-468]; [@b110-arcr-34-4-468]).

Glucocorticoids also can alter the methylation patterns of other genes. For example, glucocorticoid administration to adolescent mice reduces methylation of the *FKBP5* gene in the hippocampus, hypothalamus, and blood, which is associated with enhanced expression of *FKBP5* and increased anxiety-like behavior ([@b78-arcr-34-4-468]). The investigators proposed that in addition to altering behaviors, methylation of the gene may be a marker of cortisol burden. Polymorphisms in *FKBP5* also have been associated with psychiatric disorders, such as depression and PTSD, that are characterized by alterations in HPA dynamics ([@b14-arcr-34-4-468]; [@b158-arcr-34-4-468]).

An emerging literature also addresses the role of early-childhood adversity on the development of AUDs (for a review, see Enoch 2010). For example, [@b115-arcr-34-4-468] found an interaction between stressful early-life events and a variant in the *CRFR1* gene that influenced age of drinking initiation and drinking progression in a population of 19-year-olds. Other studies demonstrated that certain variants of the *CRFR1* gene influenced cortisol responses to CRF and the synthetic glucocorticoid dexamethasone ([@b13-arcr-34-4-468]; [@b128-arcr-34-4-468]) and were associated with binge drinking in adolescents and total lifetime alcohol consumption in adults ([@b21-arcr-34-4-468]; [@b48-arcr-34-4-468]; [@b98-arcr-34-4-468]; [@b127-arcr-34-4-468]). Thus, it seems that an interaction between the *CRFR1* gene and early-life events can modify HPA axis dynamics and risk for AUDs. It is certain that other stress gene variants also will be found to interact with environmental factors to increase the risk of AUDs.

### Current Stress

Independent of prenatal and childhood stressors, periods of severe, chronic stress in adulthood, such as family- and work-related problems, combat exposure, neighborhood violence, chronic illness, or the development of neuropsychiatric disorders, alter HPA axis dynamics and increase the cortisol burden. Chronic stress triggers an allostatic shift in the normal circadian rhythm of cortisol release as well as in stress-induced cortisol levels. Thus, after chronic stress baseline cortisol levels are elevated, the body's cortisol response to acute stress is blunted, and it takes longer for stress-induced cortisol levels to return to pre-stress levels (e.g., Juster et al. 2010; [@b85-arcr-34-4-468]; [@b154-arcr-34-4-468]). This allostatic injury makes the HPA axis more sensitive, resulting in higher cortisol exposure or greater cortisol burden following each stressful episode ([@b87-arcr-34-4-468]).

### PTSD Symptomatology

A fourth potential determinant of HPA axis activity is the presence of PTSD symptoms. The HPA axis has been the main focus of neuroendocrine research in PTSD. In a meta-analysis of 37 studies involving people with PTSD, [@b88-arcr-34-4-468] examined cortisol levels in people with PTSD and control subjects. These analyses found no differences in basal cortisol levels between the two groups; however, differences did exist under certain conditions or among certain subgroups of subjects. For example, people with PTSD had lower afternoon levels of cortisol than did control subjects, and women with PTSD had significantly lower cortisol levels than women without PTSD. The specific type of trauma experienced by a person also mattered. Thus, only people who had experienced physical or sexual abuse had significantly lower cortisol levels than control subjects. These findings highlight the complexity of the relationship between HPA axis activity and PTSD pathophysiology.

People with AUDs have a high prevalence of PTSD ([@b69-arcr-34-4-468]); conversely, women with PTSD were 3.5 times more likely to develop alcoholism than women who did not report past trauma ([@b112-arcr-34-4-468]). It is difficult to define whether the alterations in the HPA axis seen in people with PTSD by themselves modulate risk for alcoholism because, as discussed above, a history of childhood trauma also increases risk for developing PTSD as well as alcoholism ([@b12-arcr-34-4-468]; [@b33-arcr-34-4-468]). Therefore, it is possible that exposure to trauma in early childhood may confer the initial insult to HPA axis regulation that later influences the interaction between PTSD and alcohol use ([@b159-arcr-34-4-468]). This view is consistent with the finding that people with a flattened cortisol response following trauma had a higher risk of developing PTSD symptoms than did those with normal cortisol levels (e.g., [@b1-arcr-34-4-468]; [@b6-arcr-34-4-468]). It remains unclear, however, whether the lower levels of circulating cortisol preceded the traumatic event ([@b159-arcr-34-4-468]).

Regardless of whether an underlying HPA axis dysregulation precedes PTSD symptomatology, evidence suggests that dysregulation occurs through increased sensitivity of the negative feedback mechanisms regulating the HPA axis, resulting in lower circulating cortisol levels. [@b158-arcr-34-4-468] examined the expression of all genes active in whole-blood samples as well as cortisol levels in people with and without PSTD. This analysis identified 17 genes whose expression differed between people with and without PTSD. Several of the uniquely expressed genes are involved in HPA axis function. For example, the *FKBP5* gene, which serves as a modulator of GR sensitivity, showed reduced expression in people with PTSD, consistent with enhanced GR responsiveness. Moreover, statistical analyses found that *FKBP5* expression was predicted by cortisol levels when PTSD severity also was taken into consideration ([@b158-arcr-34-4-468]). Of interest, this profile of HPA axis dysregulation is distinct from that seen with other psychiatric disorders, such as depression ([@b47-arcr-34-4-468]). Taken together, it seems likely that dysregulation of the HPA axis associated with PTSD interacts with epigenetic and environmental influences ([@b159-arcr-34-4-468]) and that this interaction translates into increased risk for the development of AUDs.

The HPA Axis and Alcoholism
===========================

HPA Axis Dynamics in People at Risk for AUDs
--------------------------------------------

Altered HPA axis responsivity may be present before alcohol exerts its toxic effects on the CNS and may contribute to initial vulnerability to alcoholism. This vulnerability risk likely is a result of gene--environment interaction ([@b22-arcr-34-4-468]; [@b114-arcr-34-4-468]). The current state of knowledge stems from an early and large body of research suggesting that people who have alcoholic family members (i.e., who are family-history positive \[FHP\] for alcoholism) may be more likely to develop the disorder than those with no such family history (i.e., who are family-history negative \[FHN\] for alcoholism) ([@b153-arcr-34-4-468]). This risk seems to be linked to abnormal HPA activity (e.g., [@b24-arcr-34-4-468]; [@b74-arcr-34-4-468]; [@b125-arcr-34-4-468]; [@b130-arcr-34-4-468]; [@b146-arcr-34-4-468], [@b144-arcr-34-4-468],[@b145-arcr-34-4-468]), although the relationships appear complex. Laboratory findings have been mixed and may depend on several factors, such as which type of stressor is used, whether basal or reactive HPA response is measured, and how cortisol is stimulated. The first studies comparing HPA axis responsivity in FHP and FHN people assessed cortisol levels in response to an agent that can block the opioid receptors (i.e., the opioid receptor antagonist, naloxone). These studies identified stronger cortisol responses to naloxone in FHP subjects than in FHN subjects ([@b146-arcr-34-4-468], [@b144-arcr-34-4-468],[@b145-arcr-34-4-468],[@b141-arcr-34-4-468]). These findings were replicated using another opioid receptor antagonist, naltrexone ([@b74-arcr-34-4-468]). These observations are particularly interesting because they implicate the endogenous opioid system in the interaction between HPA axis activity and alcoholism risk. This signaling system not only modulates the HPA axis but also is a pharmacological target for the treatment of alcohol dependence. Other studies using a psychosocial stressor rather than a pharmacologic stimulator such as naloxone also found a stronger HPA response in FHP than in FHN subjects ([@b130-arcr-34-4-468]; [@b160-arcr-34-4-468],[@b161-arcr-34-4-468]). More recent studies among infants and toddlers with prenatal alcohol exposure who also are believed to be at increased risk for alcoholism have corroborated these latter findings in male but not female children ([@b45-arcr-34-4-468]; Ouellet-Morin et al. 2010). Other studies, however, found blunted HPA axis function in FHP individuals (e.g., [@b24-arcr-34-4-468]; [@b125-arcr-34-4-468]).

HPA Axis Dynamics During Intoxication and Withdrawal
----------------------------------------------------

As with stress, acute alcohol consumption also directly and indirectly activates the HPA axis by resulting in elevated levels of glucocorticoids ([@b105-arcr-34-4-468]). In fact, alcohol and other drugs of abuse have been described as a physiological stressor because they can activate the HPA axis. In social drinkers, acute doses of alcohol usually increase cortisol levels, particularly if blood alcohol levels exceed 100 mg percent ([@b139-arcr-34-4-468]). At some point during the transition from social drinking to alcohol dependence and abstinence, however, the HPA axis becomes dysregulated. For example, [@b73-arcr-34-4-468] found that cortisol reactivity to acute alcohol administration is attenuated in heavy, hazardous drinkers compared with light, social drinkers. This observation may be related to the general process of tolerance that emerges during heavy hazardous drinking. It is important to note that the subjects in this study were binge drinkers---which reflects a pattern of drinking frequently associated with adverse consequences---but were not alcohol dependent, suggesting that alterations in the HPA axis may begin even before dependence develops.

The onset of alcohol dependence, however, is accompanied by bouts of elevated cortisol levels in the blood (i.e., hypercortisolism) as the drinker cycles though repeated episodes of alcohol intoxication and the stress of withdrawal ([@b3-arcr-34-4-468]; [@b143-arcr-34-4-468]). This transition to alcohol dependence is accompanied by an allostatic shift in HPA axis functioning, resulting in abnormally low cortisol responsivity ([@b76-arcr-34-4-468]). Under conditions of alcohol dependence, the allostatic load---a hypothetical measure of cumulative stress---increases and burdens the organism with excessive exposure to stress hormones and peptides as well as pro-inflammatory cytokines ([@b86-arcr-34-4-468]). Increased allostatic load has been implicated not only in AUDs and other drug use disorders but also in the development psychiatric disorders (e.g., depression), metabolic syndrome, and systemic hypertension. In the context of drug use, allostatic load not only impacts the stress response via the HPA axis but also encompasses a state of reward dysregulation. At this point, the organism constantly seeks the initial rewarding effects of the drug while tolerance to those effects develops through repeated drug self-administration. This results in a dysfunctional reward system and a maladaptive response to stress. Specifically, the allostatic alterations in cortisol responsivity may have a detrimental effect on the reward systems ([@b140-arcr-34-4-468]).

HPA Axis Dynamics During Abstinence
-----------------------------------

[@b143-arcr-34-4-468] studied HPA axis function in alcohol-dependent subjects during the first week of abstinence following supervised alcohol withdrawal on a clinical research unit. Although the participants had modestly to highly significantly elevated cortisol levels in the urine during the withdrawal period, they also demonstrated blunted HPA axis responses to CRF, a medication that blocks cortisol production (i.e., metyrapone), and the ACTH analog cosyntropin immediately following alcohol detoxification. In fact, many of the alcohol-dependent subjects met diagnostic criteria for adrenal insufficiency. Other studies have corroborated these findings of elevated cortisol during the first week of withdrawal and also showed that cortisol levels decreased significantly over time, even plunging below the normal range ([@b36-arcr-34-4-468]; [@b68-arcr-34-4-468]; [@b81-arcr-34-4-468]).

Later in abstinence (i.e., at 2 to 6 weeks), alcoholics generally regain normal diurnal patterns of cortisol levels (e.g., [@b79-arcr-34-4-468]). However, they may continue to exhibit a deficient cortisol response to psychosocial and pharmacological HPA axis stimulation for several months ([@b3-arcr-34-4-468], [@b4-arcr-34-4-468],[@b5-arcr-34-4-468]; [@b7-arcr-34-4-468]; [@b11-arcr-34-4-468]). [@b65-arcr-34-4-468] compared HPA axis activity in early abstainers (i.e., mean abstinence 22 days) and long-term abstainers (i.e., mean abstinence 117 days). These investigators found that longer-abstaining people showed a stronger cortisol awakening response, another indicator of HPA axis function, implying that diurnal patterns of cortisol may begin to normalize over longer periods of abstinence. Whether regulation of the HPA axis returns completely to normal, and under what conditions, remains unknown.

Several factors may impact and moderate HPA axis recovery, including severity of withdrawal symptoms ([@b11-arcr-34-4-468]), severity and duration of dependence, comorbid childhood trauma ([@b113-arcr-34-4-468]), and genetic factors underlying the individual stress response. The exact role of cortisol in HPA axis recovery is unclear. [@b23-arcr-34-4-468] examined the effect of exercise as a biobehavioral stressor in control subjects and alcoholics over an 8-week period. Consistent with other studies, ACTH and cortisol levels were significantly lower in alcoholics in the first month of withdrawal; by 8 weeks, however, the hormonal response had returned to normal. Interestingly, exercise itself can induce cortisol release ([@b9-arcr-34-4-468]; [@b23-arcr-34-4-468]; [@b131-arcr-34-4-468]) and has been investigated as an adjunct for smoking cessation with somewhat promising findings ([@b152-arcr-34-4-468]). This suggests that manipulation of cortisol levels may have therapeutic potential (see below). Indeed, determining the nature, extent, and time course of the attenuated HPA axis response during abstinence may have significant clinical relevance because low levels of basal cortisol and of the ACTH response may predict relapse to alcohol use during early abstinence ([@b3-arcr-34-4-468]; [@b64-arcr-34-4-468], [@b66-arcr-34-4-468]; [@b71-arcr-34-4-468]).

No prospective longitudinal studies have examined HPA axis changes over longer periods of abstinence. One study of alcoholics who had been abstinent for a mean of 3.5 years found similar ACTH and cortisol responses compared with healthy controls in response to both psychological and pharmacological (i.e., opioid challenge) stressors ([@b91-arcr-34-4-468]). However, the study did not determine whether the alcoholics had recovered a normal level of HPA response with prolonged abstinence, whether they had had a normal response all along, or whether their lack of psychological comorbidity indicated that they were less affected by secondary characteristics related to a hyporesponsive HPA axis. Another study compared alcoholics who had relapsed with abstainers after one year and found that, contrary to findings during short-term abstinence, 1-year abstainers had significantly lower levels of cortisol ([@b138-arcr-34-4-468]). This suggests that the relationship between HPA axis activity and alcohol recovery is dynamic and changes as abstinence persists over time.

One major limitation of these studies is that most of the work has been conducted with male alcoholics; therefore, less is known regarding the HPA hyporesponsiveness during abstinence in females. [@b2-arcr-34-4-468] focused on female alcoholics and found no differences in HPA axis activity between women who had been abstinent for 4 to 8 weeks and age-matched healthy control women. Thus, HPA axis functioning over the long term and its relationship to alcohol use and recovery remains unclear and warrants further investigation.

Possible Roles of Cortisol in the Risk and Development of AUDs
==============================================================

Cortisol's Interaction with Dopaminergic Reward Systems
-------------------------------------------------------

Studies in animal models have demonstrated that mesocorticolimbic dopamine pathways are involved in the brain's reward system and that the nucleus accumbens in the ventral striatum is a critical region for mediating the rewarding effects of drugs. Virtually all drugs of abuse, including alcohol, have an impact on dopaminergic activity within this brain region ([@b101-arcr-34-4-468]). Imaging studies using positron emission tomography (PET) in humans have corroborated the animal findings that drugs of abuse alter mesolimbic dopaminergic activity and have helped elucidate potential neurobiological underpinnings of drug addiction (for a review, see Martinez and Narendran 2009). These and other studies in humans have shown that mesolimbic dopamine release is correlated with the positive subjective effects of the drug ([@b30-arcr-34-4-468]; [@b46-arcr-34-4-468]; [@b95-arcr-34-4-468]; [@b136-arcr-34-4-468]; [@b147-arcr-34-4-468]). However, whereas acute alcohol administration increases synaptic dopamine activity and accumulation, chronic alcohol consumption can lead to lower-than-normal dopamine levels (i.e., a hypodopaminergic state) that may motivate the drinker to seek alcohol in order to restore the normal levels of the neurotransmitter ([@b137-arcr-34-4-468]). It has been postulated that elevated levels of glucocorticoids contribute to alcohol's reinforcing effects by enhancing modulation of the dopaminergic and subjective response to alcohol (e.g., [@b89-arcr-34-4-468]).

Glucocorticoids and stress interact with the dopamine reward system in ways that may increase vulnerability for developing addiction ([@b83-arcr-34-4-468]). For example, glucocorticoids play a critical role in the reinforcing effects of psychostimulants because surgical removal of the adrenal glands (i.e., adrenalectomy), which prevents cortisol production, decreases drug self-administration. Moreover, re-introduction of glucocorticoids at levels similar to those induced by stress reverses this effect ([@b28-arcr-34-4-468]). In fact, acute stress and drugs of abuse, through different mechanisms, appear to converge upon a common pathway that modifies dopamine neuron output by enhancing long-term potentiation (LTP) of excitatory synapses ([@b109-arcr-34-4-468]) and long-term depression (LTD) of inhibitory synapses ([@b92-arcr-34-4-468]). However, these studies did not demonstrate that this effect directly was attributable to cortisol. Another study found that the magnitude of stress-induced cortisol release significantly correlates with mesolimbic dopamine release in the ventral striatum ([@b103-arcr-34-4-468]). Taken together, these studies suggest that cortisol may facilitate firing of dopaminergic neurons and, consequently, the reward circuitry and that this process is common with and specific to many drugs of abuse ([@b109-arcr-34-4-468]).

Glucocorticoids themselves also are believed to have reinforcing properties in rats as they seem to modulate self-administration of alcohol and increase brain sensitivity to other addictive drugs (e.g., stimulants and opioids) in the animals. A review by [@b100-arcr-34-4-468] concluded that glucocorticoid administration at levels similar to those found in physiological stress responses had positive reinforcing effects. The investigators proposed that under natural conditions (e.g., during conflicts with other animals) the rewarding effects of the glucocorticoids might counteract the aversive effects of external aggressions, thereby allowing the animal to better cope with threatening situations. Such a mechanism may play a key role in fine-tuning an individual's adaptation to stress and in determining reward-related behavioral pathologies. Thus, increased levels of cortisol may have reinforcing effects, acting on the brain to perpetuate behaviors (e.g., alcohol consumption) that maintain high cortisol levels.

The interactions of the stress response and the rewarding effects of drugs also have been investigated in humans. Imaging studies using PET found that higher cortisol levels in response to amphetamine administration ([@b95-arcr-34-4-468]) or to a psychosocial stressor ([@b147-arcr-34-4-468]) were positively associated with amphetamine-induced dopamine release in the ventral striatum. Furthermore, subjects with a high cortisol response to these stimuli reported more positive subjective drug effects after amphetamine administration than did subjects with a low cortisol response ([@b46-arcr-34-4-468]; [@b95-arcr-34-4-468]; [@b147-arcr-34-4-468]). These studies provide evidence that cortisol may play a role in drug reinforcement through its interactions with the dopaminergic reward pathway, which may, in turn, influence vulnerability for and maintenance of alcohol and other drug use.

Cortisol's Effect on Cognitive Processes
----------------------------------------

LTP is a process that ultimately enhances signal transmission at the synapse. This enhanced synaptic transmission, which has been observed in a variety of neural structures, is widely considered one of the leading cellular mechanisms that underlie learning and memory ([@b43-arcr-34-4-468]). As mentioned above, LTP is enhanced by stress. Cortisol has been implicated in this phenomenon because a wide- spread system of glucocorticoid receptors is found above the hypothalamus, for example, in the limbic system, notably the hippocampus and amygdala, and in the prefrontal cortex. This section discusses the impact of glucocorticoids on some of the basic (e.g., learning, acquisition, and memory) and higher (e.g., decision-making) cognitive processes that may potentially underlie development of addictive behaviors. This discussion focuses on the regulatory actions of glucocorticoids on neural structures critically involved in cognitive processes related to alcoholism but does not cover the equally important reciprocal effects these structures have on regulating HPA axis function (e.g., [@b26-arcr-34-4-468]).

Optimal levels of cortisol are needed not only to meet the body's physical needs but also for learning, memory, and cognitive performance. Both too little and too much cortisol may be damaging and disruptive to memory formation, whereas normal levels of glucocorticoids protect the brain against adverse events and are essential for cognitive processes. Several studies partly may explain this paradox by describing the roles of MRs and GRs in the various stages of information processing and the context in which glucocorticoid-receptor activation takes place. The effects of glucocorticoids on brain tissue as well as cognition can turn from adaptive into maladaptive when actions via both receptor types are imbalanced for a prolonged time ([@b63-arcr-34-4-468]; [@b25-arcr-34-4-468]).

The secretion of cortisol and norepinephrine in response to acute stress is known to affect learning and memory ([@b123-arcr-34-4-468]; [@b134-arcr-34-4-468]). The mammalian brain does not house a solitary brain region mediating the acquisition, consolidation, and retrieval of all types of learned information. Instead, memory and learning are organized in multiple brain systems. Certain brain regions (e.g., the pre-frontal cortex) govern goal-directed learning, whereas others (e.g., the dorsal striatum) are responsible for habit formation. Stress can induce a bias by promoting habit-based forms of learning and memory in lieu of goal-directed performance. Specifically, studies in rodents have determined that corticosterone and norepinephrine promote habit-based memory formation by acting on the amygdala, hippocampus, dorsal striatum, and prefrontal cortex---all of which also are involved in alcohol dependence. The relationship between cortisol and the vulnerability to alcohol dependence as well as to relapse after abstinence could involve cortisol's effects on habit-based learning. In view of the habit-like nature of addictive behaviors, it is fascinating that recent evidence indicates a role for the habit memory system located in the dorsal striatum in the maintenance and expression of drug-seeking and drug-taking behaviors ([@b37-arcr-34-4-468]). For example, anxiety-inducing (i.e., anxiogenic) drugs can promote the use of dorsal striatal-dependent habit memory in rats ([@b97-arcr-34-4-468]).

Research in humans also has shown that stress is associated with decreased use of cognitive behavioral strategies, which involve the hippocampus, and increased use of stimulus-response strategies, which involve the caudate nucleus ([@b72-arcr-34-4-468]; [@b118-arcr-34-4-468]). It is possible that the heightened cortisol responsivity in people at increased risk for alcohol dependence may promote the transition to heavy, hazardous drinking through cortisol's ability to promote habit-based memory formation and learning during alcohol intoxication, especially during states of heightened arousal ([@b124-arcr-34-4-468]). Furthermore, the wide fluctuations in cortisol secretion observed in alcohol-dependent people could help maintain these habit-based addictive behaviors. Additionally, the hypercortisolism associated with alcohol dependence may in part promote relapse by favoring the use of habit-based memory to guide the expression of maladaptive behaviors. Finally, persistent hypercortisolism observed during repeated episodes of acute alcohol intoxication and withdrawal may be toxic to neurons in the hippocampus. Hippocampal damage, in turn, may result in alcohol-related symptoms such as personality changes, memory loss, and depression.

Chronic exposure to elevated glucocorticoid levels also can have a detrimental effect on prefrontal cortex function with concomitant neuronal degeneration ([@b10-arcr-34-4-468]). As mentioned earlier, the prefrontal cortex is involved in complex cognitive operations, including assessing likelihood of reward or punishment during critical decision-making situations as well as assessing internal and external affective cues and responding adaptively, particularly in stressful situations. Psychosocial stress can disrupt prefrontal cortex function in humans (e.g., [@b80-arcr-34-4-468]). However, the specific effects of glucocorticoids in this process remain to be determined ([@b57-arcr-34-4-468]) because other physiological changes that occur as part of the overall stress response, such as increased catecholamine levels, also alter prefrontal cortex function ([@b104-arcr-34-4-468]). Animal studies have suggested that glucocorticoids play a role in the cognitive deficits observed after withdrawal from chronic alcohol consumption ([@b107-arcr-34-4-468]). In mice, the glucocorticoid receptor antagonist mifepristone reduced memory deficits during the first and second week after alcohol withdrawal, suggesting that heightened glucocorticoid levels during withdrawal directly contribute to these cognitive deficits ([@b62-arcr-34-4-468]). Studies in humans found that cognitive impairment in abstinent alcoholics was related to an attenuated cortisol response to a psychosocial stressor ([@b34-arcr-34-4-468]). Poorer cognitive performance also was related to more withdrawal episodes, heavier alcohol consumption, and higher cortisol levels during withdrawal ([@b34-arcr-34-4-468]; [@b68-arcr-34-4-468]). Thus, further studies should investigate the mechanism through which altered stress regulation of the HPA axis impairs cognitive function and relates to poor prognosis in recovering alcoholics.

The amygdala is another limbic structure that is affected by cortisol in ways that might contribute to alcohol dependence. The amygdala is a major extrahypothalamic source of CRF-containing neurons that carry large numbers of CRF-1 and CRF-2 receptors; it has a primary role in the processing and memory of emotional reactions. Thus, the extended amygdala is crucial for the expression of anxiety, and the central amygdala is a major extrahypothalamic site where CRF is produced and plays a role in mediating fear and anxiety ([@b44-arcr-34-4-468]; [@b50-arcr-34-4-468]). Whereas the hypothalamic CRF system is important for modulating neuroendocrine responses to stress, the extrahypothalamic CRF system manifests the behavioral response to stress via the amygdala and other limbic regions. In rats with high alcohol preference and anxiety levels, CRF gene expression is reduced in the central nucleus of the amygdala ([@b59-arcr-34-4-468]); moreover, the extracellular levels of CRF in the central amygdala are increased during acute alcohol withdrawal and during exposure to various forms of stress ([@b90-arcr-34-4-468]). Chronically elevated corticosterone levels also increase CRF expression in the central amygdala ([@b119-arcr-34-4-468]; [@b116-arcr-34-4-468]). This enhanced CRF production may contribute to anxiety-like behaviors. The heightened or exaggerated emotional and fearful reactivity to perceived stress, in turn, may drive alcohol consumption observed during heavy, hazardous drinking and alcohol dependence. Consistent with this theory, administration of CRF antagonists reverses anxiety-like behaviors and excessive alcohol drinking associated with alcohol withdrawal ([@b132-arcr-34-4-468]). These observations suggest that heightened cortisol exposure influences alcohol consumption by inducing anxiety and dysphoria via CRF-mediated activation of the amygdala.

Early Abstinence and Relapse
----------------------------

As mentioned earlier, a blunted hormonal response to stress during early abstinence is related to increased risk for relapse ([@b64-arcr-34-4-468], [@b66-arcr-34-4-468]; [@b71-arcr-34-4-468]). The mechanism underlying this relationship is not clear. Because cortisol levels in alcohol-dependent people negatively correlate with self-reported alcohol craving ([@b15-arcr-34-4-468]), it is possible that relapse to alcohol consumption during early abstinence partly is driven by alcohol's ability to induce cortisol elevation ([@b66-arcr-34-4-468]). If this is the case, cortisol may influence the motivation to drink and relapse via a potential negative-reinforcement pathway. Several observations support this hypothesis. For example, several studies evaluating pharmacological treatments for relapse prevention during early abstinence have examined the relationships among HPA activity, craving, and alcohol intake during early abstinence, based on the hypothesis that risk for relapse may be attenuated through mechanisms that reduce craving and increase cortisol. For example, [@b94-arcr-34-4-468] administered naltrexone or placebo for 6 days to alcohol-dependent, non-treatment seekers who then participated in an alcohol self-administration session. Naltrexone treatment resulted in higher cortisol levels, which were associated with lower levels of craving and less alcohol consumption. Similarly, [@b70-arcr-34-4-468] studied the efficacy of naltrexone and/or an agent that can block receptors for the neurotransmitter GABA (i.e., acamprosate), both of which are used in alcoholism treatment to reduce craving. The study found that without an active treatment, both ACTH and cortisol levels decreased during early abstinence; conversely, treatment with naltrexone and acamprosate prevented these declines. Moreover, increased ACTH and cortisol during treatment was associated with reduced risk of relapse. Finally, [@b121-arcr-34-4-468] found that alcohol-dependent patients who had been abstinent for 28 days showed significantly elevated basal cortisol levels as well as a blunted cortisol response to a psychological stressor and to exposure to an alcohol-related cue. Further, stress and cue exposure resulted in significantly enhanced and persistent craving. Although some studies have not been able to demonstrate correlations between changes in cortisol and craving (e.g., [@b102-arcr-34-4-468]), decreased cortisol levels in general have been accompanied by increased craving during early abstinence, which may underlie risk for relapse to alcohol use. Taken together, these studies suggest that cortisol levels and HPA axis reactivity may be useful clinical indicators in the management of relapse risk and that manipulating HPA axis regulation through either pharmacological or psychosocial intervention is a viable avenue of research for developing new alcoholism treatments.

Summary
=======

The HPA axis, an important physiological stress pathway, may play a significant role in the risk and development of AUDs, and the glucocorticoid cortisol may be useful as a biomarker for HPA axis homeostatic regulation. The hormones of the HPA axis act to maintain homeostasis in the presence of stress through a variety of mechanisms. When the HPA axis becomes dysregulated, regardless of cause, deviations in cortisol reactivity result that have been associated with the progressive stages of alcoholism risk, dependence, and abstinence (see [figure 2](#f2-arcr-34-4-468){ref-type="fig"}). Considerable research has been devoted to identifying potential underlying mechanisms of the HPA axis dynamics that contribute to progressive stages of alcohol dependence, and the available evidence support several of these potential mechanisms.

First, non-alcohol--dependent drinkers believed to be at risk for developing an AUD, either because of their family history or because of their hazardous drinking patterns, clearly have altered HPA axis function compared with low-risk individuals. The findings regarding the exact nature of this dysregulation (i.e., whether the HPA axis shows hyper- or hyporesponsivity) are mixed, particularly within the family-history literature. However, the equivocal results most likely are related to differences in experimental strategies used and in the levels of alcohol consumption in these drinkers (e.g., tolerance level). Nevertheless, this body of literature generally has established that cortisol responsivity serves as a risk marker for the propensity for abuse or dependence.

Second, considerable evidence supports the effect of glucocorticoids in facilitating dopamine-mediated signal transmission in the brain, which has been linked to reward pathways involved in almost all drugs of abuse. Moreover, glucocorticoids themselves have positive reinforcing properties. Conversely, reduced glucocorticoid activity seems to suppress acquisition and self-administration of drugs of abuse ([@b38-arcr-34-4-468]; [@b41-arcr-34-4-468]). Thus, glucocorticoids appear to play a critical mediating role in the dopamine reward circuit.

Third, cortisol plays a key role in brain regions that are important for cognitive learning and memory retrieval, encoding, and consolidation. These are central processes affected by shifting hyper- and hypocortisolism throughout alcohol dependence as well as by cortisol responses to stress. It is possible that such perturbations in the HPA axis consolidate the type of habit-based learning (rather than goal-directed learning) that sustains maladaptive behaviors related to alcohol use.

Finally, deficiency in cortisol response during early abstinence is predictive of relapse to alcohol and may modulate conditions that often accompany relapse episodes, such as craving, dysphoria, and severe withdrawal symptoms. Thus, cortisol levels during abstinence may be useful clinical indicators of relapse vulnerability, and interventions that increase cortisol and decrease craving might be useful to prevent relapse.

Taken together, HPA axis function may serve as a predictor of risk for alcohol dependence in alcohol-naïve or social drinkers, facilitate initiation and maintenance of alcohol use, or serve as a predictor for risk of relapse in abstinent alcohol-dependent individuals. Using HPA axis reactivity as a predictive marker may help to identify individuals at risk for dependence or relapse prior to development of those conditions, which would allow the individuals and their treatment providers to take action and improve overall prevention and treatment efforts for AUDs.
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Cortisol has similar affinity to the MR as does the mineralocorticoid aldosterone, which helps regulate kidney function

Certain tissues, however, need to be protected from cortisol, such as the kidneys, colon, and placenta. In these tissues, an enzyme, 11-β hydroxysteroid dehydrogenase type II, mediates the conversion of glucocorticoids to 11-dehydro metabolites, which are inactive.
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![The major components of the stress response mediated by the hypothalamic--pituitary--adrenal (HPA) axis. Both alcohol and stress can induce nerve cells in one brain region (i.e., the hypothalamus) to produce and release corticotropin-releasing factor (CRF). Within the hypothalamus, CRF stimulates the release of a hormone that produces morphine-like effects (i.e., β-endorphin). CRF also is transported to a key endocrine gland, the anterior pituitary gland. There, CRF stimulates production of a protein proopiomelanocortin (POMC). POMC serves as the basis for a number of stress-related hormones, including adrenocorticotropic hormone (ACTH), β-lipotropin (β-LPH), and β-endorphin. ACTH stimulates cells of the adrenal glands to produce and release the stress hormone cortisol. When cortisol levels reach a certain level, CRF and ACTH release diminishes. Other neurons releasing serotonin (5-HT), norepin ephrine (NE), γ-aminobutyric acid (GABA), or endogenous opioids also regulate CRH release.\
NOTE: = ⊕ excites; ⊖ = inhibits.](arcr-34-4-468f1){#f1-arcr-34-4-468}

![Summary of the activity of the hypothalamic--pituitary--adrenal (HPA) axis during different stages of alcoholism development and their potential consequences.\
NOTE: \*Low level of response (LR) to alcohol is a phenotype that predicts higher risk for alcohol-related problems ([@b58-arcr-34-4-468]); currently, there are no data characterizing HPA axis response to mental stress in this high-risk group. Posttraumatic stress disorder (PTSD) is a complicated disorder with multiple subtypes and comorbidities; the HPA axis profile of individuals with PTSD symptomatology generally is not thought to react to mental stress with enhanced responsivity and therefore does not fit the model depicted above for other high-risk social drinkers.](arcr-34-4-468f2){#f2-arcr-34-4-468}
